Streetbeat News

Earnings

HP

Helmerich & Payne reported Q4 2023 earnings per share (EPS) of $0.77, beating the estimate of $0.76. However, the company's revenue of $660M fell short of the estimated $663.2M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:20 pm

RAMP

LiveRamp Holdings (NYSE:RAMP) reported Q2 earnings, beating estimates by 79.17% with an EPS of $0.43 against an estimate of $0.24. Revenue was up $12.77 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by an 18.28% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:20 pm

DUOL

Duolingo reported better-than-expected Q3 sales results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:20 pm

FATE

Fate Therapeutics (NASDAQ:FATE) reported its Q3 earnings, beating estimated earnings by 19.3% with an EPS of $-0.46 versus an estimate of $-0.57. However, revenue was down $13.04 million from the same period last year. Last quarter, the company beat on EPS by $0.05, which was followed by a 3.68% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:20 pm

SCPH

scPharmaceuticals reported Q3 losses of $(0.41) per share, missing the analyst consensus estimate of $(0.36) by 13.89%. This is a 10.81% decrease over losses from the same period last year. However, the company's quarterly sales of $3.80 million beat the analyst consensus estimate of $3.39 million by 11.98%.

Portfolio Pulse from bharat@benzinga.com

November 08, 2023 | 9:20 pm

AKA

a.k.a Brands Holding reported Q3 2023 earnings per share (EPS) of $(6.58), a significant decrease from $(0.01) year-over-year (YoY). However, the company's revenue of $140.8M surpassed the estimate of $140.680M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:19 pm

ENV

Envestnet (NYSE:ENV) reported Q3 earnings of $0.56 per share, beating the analyst consensus estimate of $0.54 by 3.7%. This is a 24.44% increase from the same period last year. However, the company's quarterly sales of $316.85 million missed the analyst consensus estimate of $317.53 million by 0.22%. This is a 3.31% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:19 pm

FATE

Fate Therapeutics (NASDAQ:FATE) reported Q3 2023 GAAP EPS of $(0.46), beating the estimate of $(0.57) by 19.3%. This is a 46.51% increase over losses from the same period last year. The company also reported quarterly sales of $1.94M, beating the estimate of $890.00K by 118.43%, but this is a 87.02% decrease over sales from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 08, 2023 | 9:19 pm

MGM

MGM Resorts Intl reported Q3 earnings of $0.64 per share, beating the analyst consensus estimate of $0.49 by 30.61%. This is a 146.04% increase over losses of $(1.39) per share from the same period last year. The company also reported quarterly sales of $3.97 billion, beating the analyst consensus estimate of $3.87 billion by 2.67%. This is a 16.31% increase over sales of $3.42 billion the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:19 pm

ZIP

ZipRecruiter has projected its Q4 revenue to be between $125M and $131M, which is lower than the estimated $132.47M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:18 pm